Rad Maryam Shayani, Mohajeri Seyed Ahmad
a Student Research Committee (SRC) , Mashhad University of Medical Sciences , Mashhad , Iran.
b Pharmaceutical Research Center, School of Pharmacy , Mashhad University of Medical Sciences , Mashhad , Iran.
Curr Eye Res. 2016 Sep;41(9):1185-91. doi: 10.3109/02713683.2015.1107591. Epub 2016 Feb 2.
The purpose of the present study was to evaluate the efficacy of commercial soft contact lenses, loaded with vitamin E, as ocular drug delivery systems for simultaneous loading and release of ciprofloxacin (Cipro) and betamethasone (BMZ) in artificial tears.
In this study, we applied vitamin E as a barrier to increase BMZ-Cipro loading into three commercial silicone-based soft contact lenses and control their simultaneous release into the artificial lachrymal fluid. Two different concentrations of vitamin E solution (0.1 and 0.2 g/ml) were used, and various parameters including changes in lens diameter, water content, ultraviolet-visible light (UV-Vis) transmittance, drug-binding properties, and drug release profile were investigated.
The obtained results indicated that vitamin E significantly reduced the swelling properties of contact lenses in aqueous media, while it enhanced the lens diameter in both dry and hydrated states. Vitamin E had no significant effects on visible transmittance, while it blocked UV radiation, which could be harmful for the eye surface. Our findings revealed that vitamin E improved the simultaneous loading amount of BMZ-Cipro into soft contact lenses. Additionally, BMZ and Cipro release rates significantly reduced after using vitamin E as a hydrophobic diffusion barrier. After soaking the lenses in 0.1 and 0.2 g/ml of vitamin E solution, BMZ release time increased by 28.8-81.6 and 182.4-201 folds, respectively. Moreover, Cipro release time increased by 12-18 and 1152-2313 folds, respectively.
The results of the present study indicated the efficacy of vitamin E as a diffusion barrier in developing a controlled drug delivery system for the simultaneous loading of BMZ and Cipro and sustaining their release from soft contact lenses.
本研究旨在评估负载维生素E的商用软性隐形眼镜作为眼部给药系统在人工泪液中同时加载和释放环丙沙星(Cipro)和倍他米松(BMZ)的疗效。
在本研究中,我们应用维生素E作为屏障,以增加BMZ-Cipro加载到三种商用硅基软性隐形眼镜中,并控制它们在人工泪液中的同时释放。使用了两种不同浓度的维生素E溶液(0.1和0.2 g/ml),并研究了各种参数,包括镜片直径变化、含水量、紫外-可见光(UV-Vis)透过率、药物结合特性和药物释放曲线。
所得结果表明,维生素E显著降低了隐形眼镜在水性介质中的膨胀特性,同时在干燥和水合状态下均增大了镜片直径。维生素E对可见光透过率无显著影响,但它能阻挡对眼表有害的紫外线辐射。我们的研究结果表明,维生素E提高了BMZ-Cipro同时加载到软性隐形眼镜中的量。此外,使用维生素E作为疏水扩散屏障后,BMZ和Cipro的释放速率显著降低。将镜片浸泡在0.1和0.2 g/ml的维生素E溶液中后,BMZ的释放时间分别增加了28.8-81.6倍和182.4-201倍。此外,Cipro的释放时间分别增加了12-18倍和1152-2313倍。
本研究结果表明,维生素E作为一种扩散屏障,在开发用于同时加载BMZ和Cipro并维持其从软性隐形眼镜中释放的控释给药系统方面具有疗效。